$AMGN Company News Nasdaq breaks out, reaches

New Post Public Reply Private Reply Replies (0) Message Board

Sep 10, 2014 at 10:54 AM

$AMGN Company News

Nasdaq breaks out, reaches less-charted territory 12:05 p.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:56 a.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:44 a.m. Aug. 19, 2014 - Michael Ashbaugh
Berkshire Hathaway tops $200,000; Cisco drops on results 12:19 p.m. Aug. 14, 2014 - Angela Johnson
Cisco volatile after hours in wake of earnings 5:03 p.m. Aug. 13, 2014 - Sue Chang
Amgen recalls syringes of anemia drug Aranesp 4:55 p.m. Aug. 13, 2014 - Russ Britt
CORRECT: Amgen shares fall after-hours on disappointing trial data 4:34 p.m. Aug. 13, 2014 - Tomi Kilgore
U.S. stocks rally; Dow snaps 4-session losing streak 4:14 p.m. Aug. 4, 2014 - Barbara Kollmeyer
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Angela Johnson
Amgen shares rally 2.7% to top S&P 500 9:30 a.m. Aug. 4, 2014 - Sue Chang
Amgen reports successful late-stage trial of cancer treatment 8:34 a.m. Aug. 4, 2014 - Joshua Jamerson
Amgen reports positive trial of multiple myeloma treatment 7:49 a.m. Aug. 4, 2014 - Ciara Linnane
Tesla Shares Weaken in After Hours 8:13 p.m. July 31, 2014 - MarketWatch
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - blogs.marketwatch.com
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - MarketWatch
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - blogs.marketwatch.com
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang

Zacks Rank #1 Additions for Wednesday - Tale of the Tape 9:30 a.m. Today - Zacks.com
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015 7:44 a.m. Sept. 9, 2014 - 247WallSt.com
Royal Dutch Shell Bond Issue Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More 6:26 p.m. Sept. 8, 2014 - Seeking Alpha
Zenith Epigenetics Strengthens its Management Team with Key Appointments 5:34 p.m. Sept. 8, 2014 - CNW Group
3 Stocks Reiterated As A Buy: EBAY, AIG, AMGN 4:48 p.m. Sept. 8, 2014 - TheStreet.com
There Is Further Upside Potential In Regeneron Pharmaceuticals 1:23 p.m. Sept. 8, 2014 - Seeking Alpha
Challenging Consensus On PCSK9 Inhibitors: Focus On Regeneron And Amgen 11:39 a.m. Sept. 8, 2014 - Seeking Alpha
Amgen Is A Great Biotech Stock With A Dividend Kicker 11:22 a.m. Sept. 8, 2014 - Seeking Alpha
Amgen Inc. (AMGN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Sept. 8, 2014 - Zacks.com
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label 7:00 a.m. Sept. 8, 2014 - TheStreet.com
College Try: To Offset Tuition, a Bet on Health Care 4:02 p.m. Sept. 7, 2014 - The Wall Street Journal Interactive Edition
Why Gilead Sciences, Inc. Is A Top Mutual Fund Holding 8:27 a.m. Sept. 5, 2014 - benzinga.com
Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab - Analyst Blog 6:00 p.m. Sept. 4, 2014 - Zacks.com
Sanofi Reports Positive Phase III Data on Dengue Vaccine - Analyst Blog 6:40 p.m. Sept. 3, 2014 - Zacks.com
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status - Analyst Blog 5:20 p.m. Sept. 3, 2014 - Zacks.com
Determining Celgene's Fair Value 11:24 a.m. Sept. 3, 2014 - Seeking Alpha
Exelixis Slumps 55% on Disappointing Cabozantinib Results - Analyst Blog 10:40 a.m. Sept. 3, 2014 - Zacks.com
Biotech Stock Roundup: United Therapeutics Up on Court Ruling, Amgen Files PCSK9 Inhibitor - Analyst Blog 10:10 a.m. Sept. 3, 2014 - Zacks.com
United Therapeutics Soars on Remodulin Patent Case Win - Analyst Blog 6:25 p.m. Sept. 2, 2014 - Zacks.com
Regeneron/Sanofi Presents Encouraging Alirocumab Data - Analyst Blog 4:30 p.m. Sept. 2, 2014 - Zacks.com

Reporting Bias in Clinical Trials: What's the current status? 23 min ago - PR Newswire - PRF
Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting 9:15 a.m. Today - PR Newswire - PRF
Critical Alerts For Alcoa, Twitter, General Mills, SunEdison and Amgen Released By InvestorsObserver 9:31 a.m. Sept. 9, 2014 - PR Newswire - PRF
Zenith Epigenetics Strengthens its Management Team with Key Appointments 5:34 p.m. Sept. 8, 2014 - PR Newswire - PRF
Fitch Affirms Amgen's IDR at 'BBB'; Outlook Remains Negative 3:13 p.m. Sept. 8, 2014 - BusinessWire - BZX
The Psoriatic Arthritis Market Will Reach More than $3.5 Billion in 2023, Owing to Continued Uptake of Biologics and Penetration of Premium-Priced Orals 10:00 a.m. Sept. 8, 2014 - PR Newswire - PRF
Amgen To Present At The Morgan Stanley Global Healthcare Conference 4:04 p.m. Sept. 5, 2014 - PR Newswire - PRF
Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck 9:00 a.m. Sept. 5, 2014 - PR Newswire - PRF
Cleveland Clinic's 2014 Medical Innovation Summit Examines Cancer Treatment And Personalized Medicine 11:20 a.m. Sept. 4, 2014 - PR Newswire - PRF
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate 8:15 a.m. Sept. 4, 2014 - PR Newswire - PRF
Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 8:15 a.m. Sept. 2, 2014 - PR Newswire - PRF
Amgen Submits Marketing Authorization Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The European Medicines Agency 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic 9:30 a.m. Aug. 28, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol 9:15 a.m. Aug. 28, 2014 - PR Newswire - PRF
Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9:00 a.m. Aug. 28, 2014 - PR Newswire - PRF
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 9:15 a.m. Aug. 27, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Timothy Leyden Retires As Western Digital CFO, Succeeded By Olivier Leonetti Of Amgen And Formerly At Dell 4:15 p.m. Aug. 25, 2014 - PR Newswire - PRF
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Voting for Future Urban Icons Begins Globally

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

BAIC FOTON Eyes Africa for Bold Expansion Moves

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Langford Chosen for Navy Mutual's 2026 Bolles Award

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Karma Automotive Debuts High-Stakes Eximius Program

Breaking Ground with Bespoke Engineering Fancy seeing a car more unique than a snowflake, eh? Well, Karma Automotive is upending the luxury vehicle market with the launch of the Eximius program. Catering to the whims of the elite who aren’t just satisfied with a plethora of options, this is a game for those who crave a motorized extension of their ego and address book....

SKYWORTH Solar's Solavita: Energizing Global Microgrids

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...